Advanced Therapies: Innovations in CMC Conference

Solutions for CMC challenges in the development and commercialization of cell therapy, gene therapy, and gene editing products.

Back to Agenda

Opening Remarks and Keynote Address

Owner, KM Intel LLC, United States

Opening Remarks and Keynote Address

Speaker

Peter Marks, MD, PhD

Senior Vice President, Molecul, Eli Lilly and Company, United States

Have an account?